Skip to content

Comparative study of double plastic stents and covered self-expansible metal stents in ERCP preoperative biliary decompression of resectable/borderline resectable low malignant biliary obstruction

Comparative study of double plastic stents and covered self-expansible metal stents in ERCP preoperative biliary decompression of resectable/borderline resectable low malignant biliary obstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095326
Enrollment
Unknown
Registered
2025-01-06
Start date
2025-01-07
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low malignant biliary obstruction

Interventions

Control group:Preoperative drainage using a covered self-expansible metal stent
Experimental group:Preoperative drainage using double plastic stents

Sponsors

Department of Gastroenterology, Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients may choose to enter the study when they meet all of the following criteria: (1) Patients with pathological results showing periampullary tumors, assessed as resectable or junctionally resectable; (2) Patients with pathological diagnosis of low-level malignant biliary obstruction and need to reduce yellowing of ERCP before surgery.

Exclusion criteria

Exclusion criteria: Patients cannot be selected for clinical study when they have any of the following: (1) Patients with pathological diagnosis of unresectable malignant tumors; (2) hilar bile duct stenosis; (3) Combined with acute cholecystitis or obstructive pancreatitis; (4) Upper gastrointestinal surgery; (5) Presence of ERCP contraindications; (6) There are reasons why other researchers believe that it is not appropriate to participate in clinical trials.

Design outcomes

Primary

MeasureTime frame
Rate of stent failure;

Secondary

MeasureTime frame
Stent patent time;The decrease of serum bilirubin of patients within 2 weeks after stent placement;Operation time required for the first-time stent placement and stent replacement by ERCP;Success rate of the first-time stent placement and stent replacement by ERCP;The total times of stent replacement within 1 year after the first stent placement in this research;Incidence of ERCP-related adverse events;The interval between stent placement and the resection surgery ;Success rate of resection surgery, time required for the resection surgery, volume of bleeding during the resection surgery, the incidence of surgery-related adverse events, incidence of postoperative adverse events, postoperative hospitalization stay, postoperative survival time;Medical expense for stent placement;The total medical expense;The total hospitalization stay;

Countries

China

Contacts

Public ContactWang Qiang

Department of Gastroenterology, Peking Union Medical College Hospital

pekingunion@aliyun.com+86 152 4793 4552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026